PFE compared with PCAR: revenue, margins and what each company keeps, and the suppliers and customers both name

PFEPfizer Inc

Mkt capRevenueRevenue

PCARPaccar Inc

Mkt capRevenueRevenue

Compare

PFEPfizer Inc

PCARPaccar Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

PFE: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PFE 34

MIRMMirum Pharmaceuticalscustomer

ICUIICU Medicalcustomer

BEAMBeam Therapeuticssupplier

ADPTAdaptive Biotechnologiessupplier

30 more · PFE chain ›

Shared 0

No shared counterparties.

Only PCAR 13

ETNEatonsupplier

CMICumminssupplier

RUSHARush Enterprises Inc TXcustomer

ATMUAtmus Filtration Technologiessupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

9 more · PCAR chain ›

Price

rebased to 0%

PFE, solidPCAR, dashed

PFEPfizer Inc

30.50▲+1.83%· post 30.46

Mkt cap$174.0BRevenue$15.0BQ2 FY26Revenue$62.6BFY25

PCARPaccar Inc

101.93▼−0.36%· post 102.24

ClosedOct 30 '26

Mkt cap$53.7BRevenue$7.9BQ3 FY26Revenue$28.4BFY25

Compare

ClosedOct 30 '26

PFEPfizer Inc

PCARPaccar Inc

30.50▲+1.83%post 30.46

Price

101.93▼−0.36%post 102.24

$174.0B

Mkt cap

$53.7B

Q2 FY26$15.0B

Revenue

$7.9BQ3 FY26

FY25$62.6B

Revenue

$28.4BFY25

PFE30.50▲+1.83%vsPCAR101.93▼−0.36%ClosedOct 30 '26